Prognostic value of serial serum interleukin-6 level estimation in patients with lung cancer: A preliminary report

Yale Journal of Biology and Medicine

Volumn 70, Issue 2, 1997, Pages 139-148

  Wojciechowska Lacka, Arleta ^a   Adamiak, Ewa ^a   Stryczynska, Grazyna ^a   Lacki, Jan K ^b  

^a Wielkopolska Cancer Center   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 6;

ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN DETERMINATION; TREATMENT OUTCOME;

ACUTE-PHASE PROTEINS; ALPHA 1-ANTICHYMOTRYPSIN; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; MALE; OROSOMUCOID; PREDICTIVE VALUE OF TESTS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031415451     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Akira, S. and Kishimoto, T. IL-6 and NF-IL-6 in acute-phase response and viral infection. Immunol. Rev. 127:25-48, 1992.
2. Defrance, T., Vanbervliet, B., Briere, F., Durand, I., Rousset, F., and Bancherrau, J. Interleukin-10 and transforming growth factor beta cooperate to induce anti CD40 activated naive human B cells to secrete immnoglobulin A. J. Exp. Med. 175:671-682, 1992.
3. Richards, C.D., Brown, T.J., Shoyab, M., Baumann, H., and Gauldie, J. Recombinant oncostatin M stimulates the production of acute-phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 148:1731-1736, 1992.
4. Schooltink, H., Stoyan, T., Roeb, E., Heinrich, P.C. and Rose-John, S. Ciliary neutrophic factor induces acute-phase protein expression in hepatocytes. FEBS Lett. 314:280-284, 1992.
5. Gauldie, J., Richards, C., Harnish, D., Landsdorp, P. and Baumann, H. Interferon beta-2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute-phase response in liver cells. Proc. Natl. Acad. Sci. USA 84:7251-7255, 1987.
6. Le, J. and Vilcek, J. Biology of disease. Interleukin-6: A multifunctional cytokine regulating immune reactions and the acute-phase proteins response. Lab. Inv. 61:588-595, 1989.
7. Givon, T., Slavin, S., Haran-Ghera, N., Michalevicz, R. and Revel, M. Antitumor effects of human recombinant interleukin-6 on acute myeloid leukemia in mice and in cell cultures. Blood 79:2392-2398, 1992.
8. van Gameren, M.M., Willemse, P.H.B., Mulder, N.H., Limburg, P.C., Groen, H.J.M., Vellenga, E. and de Vries, E.G.E. Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 84:1434-1441, 1994.
9. Veldhuis, G.J., Willemse, P.H.B., Sleijfer, D.T., van der Graaf, W.T.A., Groen, H.J.M., Limburg, P.C., Mulder, N.H. and de Vries, E.G.E. Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer. J. Clin. Oncol. 13:2585-2593, 1995.
10. Zhang, X.G., Klein, B. and Bataille, R. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multple myeloma. Blood 74:11-13, 1989.
11. Staal-van den Brekel, A.J., Dentener, M.A., Schols, A.M.W.J., Buurman, W.A. and Wouters, E.F.M. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J. Clin. Oncol. 13:2600-2605, 1995.
12. Blay, J.Y., Negrier, S., Combaret, V., Attali, S., Goillot, E., Merrouche, Y., Mercatello, A., Ravault, A., Tourani, J.M. and Moskovtchenko, J.F. Serum level of interelukin-6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res. 52:3317-3322,1992.
13. Laurell, C.B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Scand. J. Clin. Invest. 124(Suppl.):2-28, 1973.
14. Fassbender, K., Zimmerli, W., Kissling, R., Sobieska, M., Aeschlimann, A., Kellner, M. and Muller, W. Glycosylation of alpha I -acid glycoprotein in relation to duration of disease in acute and chronic infection and inflammation. Clin. Chim. Acta 203:315-327, 1991.
15. Mackiewicz, A., Marcinkowska-Pieta, R., Ballou, S., Mackiewicz, S. and Kushner, I. Microheterogeneity of alpha-1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus. Arthritis Rheum. 30:513-517, 1987.
16. Spiro, S.G. Epidemiology of lung cancer. In: Hoogstraten, B., Addis, B.J., Hansen, H.H., Martini, N. and Spiro, S.G. (eds.). Lung Tumors: Berlin-Heidelberg-New York-London-Paris-Tokyo: Springer-Verlag; 1991, pp. 3-8.
17. Hansen, J.E., Iversen, J., Lihme, A. and Bog-Hansen, T.C. Acute-phase reaction, heterogeneity and microheterogeneity of serum proteins as nonspecific marker in lung cancer Cancer 60:1630-1635, 1987.
18. Milroy, R., Shapiro, D., Shenkin, A., and Banham, S.W. Acute-phase reaction during chemotherapy in small cell lung cancer. Br. J. Cancer 59:933-935, 1989.
19. Tamura, S., Nishigaki, T., Moriwaki, Y., Fujioka, H., Nakano, T., Fujii, J., Yamamoto, T., Nabeshima, K., Hada, T. and Higashino, K. Tumor markers in pleural effusion diagnosis. Cancer 61:298-302, 1988.
20. Yanagawa, H., Sone, S., Takahashi, Y., Haku, T., Yano, S., Shinohara, T., and Ogura, T. Serum level of interleukin-6 in patients with lung cancer. Br. J. Cancer 71:1095-1098, 1995.
21. Wojciechowska-Lacka, A., Matecka-Nowak, M., Adamiak, E., Lacki, J.K., and Cerkaska-Gluszak, B. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer. Neoplasma 43:155-158, 1996.